References
- Billich, A., Bornancin, F., Devay, P., Mechtcheriakova, D., Urtz, N. and Baumruker, T. (2003) Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278, 47408-47415. https://doi.org/10.1074/jbc.M307687200
- Brinkmann, V. (2009) FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. Br. J. Pharmacol. 158, 1173-1182. https://doi.org/10.1111/j.1476-5381.2009.00451.x
- Claus, R., Russwurm, S., Meisner, M., Kinscherf, R. and Deigner, H. P. (2000) Modulation of the ceramide level, a novel therapeutic concept? Curr. Drug Targets 1, 185-205. https://doi.org/10.2174/1389450003349272
- Hannun, Y. A. and Obeid, L. M. (1995) Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20, 73-77. https://doi.org/10.1016/S0968-0004(00)88961-6
- Hengst, J. A., Wang, X., Sk, U. H., Sharma, A. K., Amin, S. and Yun, J. K. (2010) Development of a sphingosine kinase 1 specific small-molecule inhibitor. Bioorg. Med. Chem. Lett. 20, 7498-74502. https://doi.org/10.1016/j.bmcl.2010.10.005
- Hla, T., Lee, M. J., Ancellin, N., Paik, J. H. and Kluk, M. J. (2001) Lysophospholipids-receptor revelations. Science 294, 1875-1878. https://doi.org/10.1126/science.1065323
- Igarashi, Y., Hakomori, S., Toyokuni, T., Dean, B., Fujita, S., Sugimoto, M., Ogawa, T., Ghendy, K. and Racker, E. (1989) Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry 28, 6796-6800. https://doi.org/10.1021/bi00443a002
- Johnson, K. R., Becker, K. P., Facchinetti, M. M., Hannun, Y. A. and Obeid, L. M. (2002) PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. J. Biol. Chem. 38, 35257-35262.
- King, C. C., Zenke, F. T., Dawson, P. E., Dutil, E. M., Newton, A. C., Hemmings, B. A., and Bokoch, G. M. (2000) Sphingosine is a novel activator of 3-phosphoinositide-dependent kinase 1. J. Biol. Chem. 275, 18108-18113. https://doi.org/10.1074/jbc.M909663199
- Kluk, M. J. and Hla, T. (2002) Signaling of sphingosine-1-phosphate via the SIP/EDG-family of G-protein-coupled receptors. Biochim. Biophys. Acta. 1582, 72-80. https://doi.org/10.1016/S1388-1981(02)00139-7
- Kwon, Y. B., Kim, C. D., Youm, J. K., Gwak, H. S., Park, B. D., Lee, S. H., Jeon S., Kim, B. J., Seo, Y. J., Park, J. K. and Lee, J. H. (2007) Novel synthetic ceramide derivatives increase intracellular calcium levels and promote epidermal keratinocyte differentiation. J. Lipid Res. 48,1936-1943 https://doi.org/10.1194/jlr.M700185-JLR200
- Lee, M. J., Van Brocklyn, J. R., Thangada, S., Liu, C. H., Hand, A. R., Menzeleev, R., Spiegel, S. and Hla, T. (1996) Sphingosine 1-phosphate as a ligand for the G-protein-coupled receptor EDG-1. Science 279, 1552-1555.
- Maceyka, M., Payne, S.G., Milstien, S. and Spiegel, S. (2002) Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta. 1585, 193-201. https://doi.org/10.1016/S1388-1981(02)00341-4
- McDonald, O. B., Hannun, Y. A., Reynolds, C. H. and Sahyoun, N. (1991) Activation of casein kinase II by sphingosine. J. Biol. Chem. 266, 21773-21776.
- Megidish, T., White, T., Takio, K., Titani, K., Igarashi, Y. and Hakomori, S. (1995) The signal modulator protein 14-3-3 is a target of sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3 (A31) cells. Biochem. Biophys. Res. Commun. 216, 739-747. https://doi.org/10.1006/bbrc.1995.2684
- Ogretmen, B. and Hannun, Y. A. (2001) Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance. Drug Resist. Updat. 4, 368-377. https://doi.org/10.1054/drup.2001.0225
- Olivera, A., Rosenfeldt, H.M., Bektas, M., Wang, F., Ishii, I., Chun, J., Milstien, S. and Spiegel, S. (2003) Sphingosine kinase type 1 induces G12/13-mediated stress fi ber formation, yet promotes growth and survival independent of G protein-coupled receptors. J. Biol. Chem. 278, 46452-46460. https://doi.org/10.1074/jbc.M308749200
- Paugh, S. W., Payne, S. G., Barbour, S. E., Milstien, S. and Spiegel, S. (2003) The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS Lett. 554, 189-193. https://doi.org/10.1016/S0014-5793(03)01168-2
- Pitman, M. R. and Pitson S. M. (2010) Inhibitors of the sphingosine kinase pathway as potential therapeutics. Curr. Cancer Drug Targets 10, 354-367. https://doi.org/10.2174/156800910791208599
- Pyne, S. and Pyne, N. J. (2000) Sphingosine 1-phosphate signaling in mammalian cells. Biochem. J. 349, 385-402. https://doi.org/10.1042/0264-6021:3490385
- Pyne, N. J. and Pyne, S. (2008) Sphingosine 1-phosphate, lysophosphatidic acid and growth factor signaling and termination. Biochim. Biophys. Acta. 1781, 467-476. https://doi.org/10.1016/j.bbalip.2008.05.004
- Sharma, A. K., Sk, U. H., Gimbor, M. A., Hengst, J. A., Wang, X., Yun, J. and Amin, S. (2010) Synthesis and bioactivity of sphingosine kinase inhibitors and their novel aspirinyl conjugated analogs. Eur. J. Med. Chem. 45, 4149-4156. https://doi.org/10.1016/j.ejmech.2010.06.005
- Spiegel, S., English, D. and Milstien, S. (2002) Sphingosine 1-phosphate signaling: providing cells with a sense of direction. Trends Cell Biol. 12, 236-242. https://doi.org/10.1016/S0962-8924(02)02277-8
- Walter S., and Fassbender K. (2010) Spingolipids in Multiple Sclerosis. Cell Physiol. Biochem. 26, 49-56. https://doi.org/10.1159/000315105
- Watterson, K., Sankala, H., Milstien, S. and Spiegel, S. (2003) Pleiotropic actions of sphingosine-1-phosphate. Prog. Lipid Res. 42, 344-357. https://doi.org/10.1016/S0163-7827(03)00015-8
- Xia, P., Wang, L., Gamble J.R. and Vadas, M.A. (1999) Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J. Biol. Chem. 274, 34499-34505. https://doi.org/10.1074/jbc.274.48.34499
- Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A., Wattenberg, B. W., D’Andrea, R. J. and Vadas, M. A. (2000) An oncogenic role of sphingosine kinase. Curr. Biol. 10, 1527-1530. https://doi.org/10.1016/S0960-9822(00)00834-4